Citius Pharmaceuticals Chairman Myron Holubiak's 2022 pay falls 26% to $1.2M
Citius Pharmaceuticals reports 2022 executive compensation
By ExecPay News
Published: December 22, 2022
Citius Pharmaceuticals reported fiscal year 2022 executive compensation information on December 22, 2022.
In 2022, four executives at Citius Pharmaceuticals received on average a compensation package of $1M, a 9% increase compared to previous year.
Average pay of disclosed executives at Citius Pharmaceuticals
Myron Holubiak, Chairman, received $1.2M in total, which decreased by 26% compared to 2021. 50% of Holubiak's compensation, or $620K, was in option awards. Holubiak also received $170K in non-equity incentive plan and $450K in salary.
Leonard Mazur, Chief Executive Officer, received a compensation package of $1.2M, which increased by 51% compared to previous year. 52% of the compensation package, or $620K, was in option awards.
Myron S. Czuczman, Chief Medical Officer, earned $888K in 2022, a 23% increase compared to previous year.
Jaime Bartushak, Chief Financial Officer, received $809K in 2022, which increases by 34% compared to 2021.
Citius Pharmaceuticals' fiscal year ends on September 30.
Related executives
You may also like
Source: SEC filing on December 22, 2022.